NeoGenomics (NASDAQ:NEO) Announces Quarterly Earnings Results, Beats Estimates By $0.01 EPS

NeoGenomics (NASDAQ:NEO) released its earnings results on Tuesday. The medical research company reported $0.07 earnings per share (EPS) for the quarter, beating the $0.06 by $0.01, Bloomberg Earnings reports. The business had revenue of $104.70 million for analyst estimates of $99.38 million. NeoGenomics had a net margin of 0.55% and a return on equity of 4.60%. NeoGenomics’s revenue for the quarter was up 51.5% on a year-over-year basis. During the same quarter in the previous year, the busines…

Original Source